Prevest Denpro Q4 FY26 Results: PAT up 13% YoY

What changed in Prevest Denpro’s March 2026 quarter

Prevest Denpro Limited, a manufacturer of dental materials, reported its Q4 FY26 (quarter ended March 31, 2026) results on May 27, 2026. The company operates in the Dental Products and Biomaterials segment and is listed as NSE: PREVESTLTD and BSE: PREVEST. The update showed a modest increase in revenue from operations, while profitability indicators were stronger. The company is described as heavily export-oriented in the provided data. A key talking point from the quarter was margin expansion, as operating profitability improved faster than the top line.

Q4 FY26 revenue: steady growth on a high base

Revenue from operations for Q4 FY26 was reported at ₹18.90 crore, compared with ₹18.54 crore in Q4 FY25, a year-on-year increase of about 1.9% (also cited as +1.95% YoY). Another figure in the same dataset pegs Q4 FY26 revenue at ₹18.94 crore, with +2.60% QoQ and +2.66% YoY. The quarterly table provided also shows net sales of ₹18.90 crore for Mar 2026. Across these references, the central point remains consistent: revenue growth in the March 2026 quarter was positive but measured.

Q4 FY26 profitability: margin expansion stands out

The snapshot cites Q4 FY26 net profit at ₹5.82 crore, up 23.31% quarter-on-quarter and 13.23% year-on-year. Separately, “reported standalone quarterly numbers” cite net profit of ₹6.06 crore in March 2026, up 15.55% from ₹5.25 crore in March 2025. EBITDA for the quarter was cited at ₹8.55 crore, up 11.04% from ₹7.70 crore a year earlier. Operating margin (excluding other income) was stated at 36.48%, up 506 bps QoQ and 103 bps YoY, alongside operating profit (PBDIT excluding other income) of ₹6.91 crore. The quarterly results table also reports operating profit of ₹7.09 crore for Mar 2026 and profit before tax (PBT) of ₹8.05 crore. Adjusted EPS for Mar 2026 was ₹5.05, up from ₹4.37 in Mar 2025.

Full-year FY26 performance: revenue and profit both higher

For the fiscal year ended March 31, 2026, Prevest Denpro reported standalone revenue of ₹71.66 crore, up from ₹63.07 crore in FY25, reflecting 13.6% growth. Standalone net profit rose to ₹21.42 crore from ₹18.20 crore in FY25, up 17.7%. The company also disclosed consolidated revenue of ₹71.81 crore and consolidated net profit of ₹20.49 crore for FY26. Total income for FY26 was reported at ₹76.66 crore, up from ₹67.18 crore in the previous year. The annual EPS improved to ₹17.84 from ₹15.16, as cited in the dataset. An unmodified auditor opinion was reported, indicating clean financial reporting.

Growth metrics and balance-sheet notes mentioned in the data

The dataset highlights sales growth of 11.74% and profit growth of 12.89% (context not further specified in the text). It also states that over the past three years, the company has shown profit growth of 16.3066905505681% and revenue growth of 18.281551943924%. A separate “Growth Rate” section lists revenue growth at 7.02%, net income growth at 13.96%, and cash flow change at 27.54%, along with ROE at -5.55% and ROCE at -5.17%. The same snapshot says the company is “almost debt free.” Reserves and surplus were reported at ₹113.82 crore as of March 31, 2026, up from ₹93.60 crore a year earlier.

Stock price, valuation marker, and listed peers

Prevest Denpro was reported trading at ₹378.55 on Thu Jun 25 2026 09:58:01. Another reference states the shares closed at ₹386.55 on May 26, 2026 (BSE). The dataset also notes the stock trading at 24.02 times trailing twelve-month earnings. Listed peers named in the snapshot include Lenskart Solutions (-1.65%), Poly Medicure (-%), and One Global Service Provider (-1.07%). Mutual fund holding for Prevest Denpro is shown as “-%” in the provided text, with the change from last quarter also shown as “-”, indicating the snapshot does not provide a usable number.

Quarterly trend snapshot from FY25 to FY26

The quarterly table provided shows net sales moving within a relatively narrow band across FY26 quarters, while Mar 2026 appears strongest for operating profit and EPS among the rows shown. Operating profit was ₹7.09 crore in Mar 2026 versus ₹6.22 crore in Dec 2025, and PBT increased to ₹8.05 crore from ₹6.87 crore over the same period. Adjusted EPS rose to ₹5.05 in Mar 2026 from ₹4.29 in Dec 2025. These reported quarterly movements align with the narrative of profit growing faster than revenue during the period.

Key numbers at a glance

Detailed quarterly figures provided (₹ crore, EPS in ₹)

Why this quarter matters for investors tracking dental materials

The March 2026 quarter combines two elements that markets typically watch closely: stable demand and improving profitability. In the numbers provided, revenue growth is low single-digit year-on-year, but operating metrics such as EBITDA and operating margin show a sharper improvement. That gap suggests the company’s cost structure and execution had a larger role than pure volume growth in driving quarterly outcomes. The FY26 annual performance adds context, with revenue rising 13.6% and standalone profit rising 17.7% for the year.

Closing takeaways

Prevest Denpro’s Q4 FY26 update points to steady revenue and stronger profitability, supported by a margin expansion narrative in the data. The FY26 annual numbers also show higher revenue and profit compared with FY25 on a standalone basis, with consolidated profit reported at ₹20.49 crore. The company’s next set of disclosures will further clarify whether the margin improvements seen in Q4 FY26 sustain into FY27, but the current snapshot already documents a stronger profit profile alongside modest top-line growth.